Exhibit 10.5
|
CONFIDENTIAL TREATMENT
REQUESTED
|
|
EXECUTION VERSION
|
|
UNDER 17 C.F.R
§§ 200.80(b)4, AND 240.24b-2
|
|
|
CALL OPTION AGREEMENT
BY AND AMONG
ISIS PHARMACEUTICALS, INC.,
IBIS BIOSCIENCES, INC.
AND
ABBOTT MOLECULAR INC.
January 30, 2008
TABLE OF CONTENTS
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
ARTICLE I
DEFINITIONS
|
|
1
|
|
|
|
|
|
|
|
ARTICLE II GRANT OF CALL OPTION;
SUBSCRIPTION RIGHTS
|
|
2
|
|
|
|
|
|
|
|
Section 2.1
|
|
Grant of
Option
|
|
2
|
|
|
|
|
|
|
|
Section 2.2
|
|
Subscription
Right
|
|
2
|
|
|
|
|
|
|
|
Section 2.3
|
|
Purchase
Price
|
|
2
|
|
|
|
|
|
|
|
Section 2.4
|
|
Milestone
Adjustments
|
|
2
|
|
|
|
|
|
|
|
ARTICLE III EXERCISE OF OPTION
|
|
3
|
|
|
|
|
|
|
|
Section 3.1
|
|
Exercise of
Call Option
|
|
3
|
|
|
|
|
|
|
|
Section 3.2
|
|
Exercise of
Subscription Right
|
|
4
|
|
|
|
|
|
|
|
Section 3.3
|
|
Call Option
Extension
|
|
4
|
|
|
|
|
|
|
|
Section 3.4
|
|
Call Option
Acceleration
|
|
4
|
|
|
|
|
|
|
|
Section 3.5
|
|
Effect of
Expiration and Termination of Call Option, Subscription
Right
|
|
5
|
|
|
|
|
|
|
|
Section 3.6
|
|
Call Option
Exercise and Subscription Right Exercise Preparation
|
|
5
|
|
|
|
|
|
|
|
ARTICLE IV MISCELLANEOUS
PROVISIONS
|
|
6
|
|
|
|
|
|
|
|
Section 4.1
|
|
Assignment
|
|
6
|
|
|
|
|
|
|
|
Section 4.2
|
|
Notices
|
|
6
|
|
|
|
|
|
|
|
Section 4.3
|
|
Counterparts
|
|
7
|
|
|
|
|
|
|
|
Section 4.4
|
|
Amendment
|
|
7
|
|
|
|
|
|
|
|
Section 4.5
|
|
Severability
|
|
7
|
|
|
|
|
|
|
|
Section 4.6
|
|
Remedies
Cumulative
|
|
8
|
|
|
|
|
|
|
|
Section 4.7
|
|
Governing Law;
Alternative Dispute Resolution
|
|
8
|
|
|
|
|
|
|
|
Section 4.8
|
|
Rules of
Construction
|
|
8
|
|
|
|
|
|
|
|
Section 4.9
|
|
Further
Assurances
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibits
|
|
|
|
|
|
A
|
Form of Stock
Purchase Agreement
|
|
|
|
B
|
Form of Stock
Subscription Agreement
|
|
|
|
C
|
[***] Milestone and
Value Accretion Milestones
|
|
|
|
D
|
Option
Notice
|
|
|
|
|
|
|
|
|
|
|
i
CALL OPTION AGREEMENT
THIS CALL OPTION AGREEMENT (this “
Agreement ”) is made and entered into as of this 30th
day of January 2008, by and among Isis
Pharmaceuticals, Inc., a Delaware corporation (“
Isis ”), Ibis Biosciences, Inc., a Delaware
corporation (“ Ibis ”), and Abbott Molecular
Inc., a Delaware corporation (“ AMI ”).
Isis, Ibis and AMI are sometimes referred to herein individually as
a “ Party ,” and collectively as the “
Parties .”
RECITALS
WHEREAS , on the
date hereof, the Parties have entered into a Strategic Alliance
Master Agreement (the “ Master Agreement ”) and
certain other Investment Documents, pursuant to which, among other
things, AMI has acquired the Shares from Ibis;
WHEREAS , in
connection with the transactions contemplated by the Investment
Documents, Isis has agreed to grant an option to AMI and AMI has
agreed to acquire from Isis an option for AMI to acquire all of the
Capital Stock (other than the Shares (and the Additional Shares if
AMI elects to acquire the Additional Shares pursuant to the Stock
Subscription Agreement)) of Ibis (the “ Optioned Stock
”) from Isis on the terms set forth in this Agreement and the
Acquisition Agreement;
WHEREAS , in
connection with the transactions contemplated by the Investment
Documents, Ibis has agreed to grant a subscription right to AMI and
AMI has agreed to acquire from Ibis a subscription right to
subscribe for and acquire the Additional Shares from Ibis on the
terms set forth in this Agreement and the Stock Subscription
Agreement; and
WHEREAS, the
execution and delivery of this Agreement by Isis and Ibis is a
material inducement for AMI to enter into the Master Agreement and
to acquire the Shares.
NOW, THEREFORE , in
consideration of the mutual promises, representations, warranties,
and covenants hereinafter set forth and for other good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, the Parties hereby agree as follows:
ARTICLE I
DEFINITIONS
Capitalized terms used but not defined herein
have the meanings ascribed to such terms in the Master
Agreement. In addition to the terms defined elsewhere herein
and in the Master Agreement, the following terms when used in this
Agreement have the following meanings:
“ Acquisition Agreement ”
means the form of Stock Purchase Agreement attached hereto as
Exhibit A .
“ Call Option Expiration Date
” means 5:00 p.m. (Pacific Time) on the date the Call
Option expires pursuant to the terms hereof, which, subject to
Section 3.1 , Section 3.2 ,
Section 3.3 and Section 3.4 , shall be
December 31, 2008.
“ Call Period ” means the
period of time commencing on the date hereof and ending on the Call
Option Expiration Date.
“ Cut-Off Date ”
means, subject to Section 3.2 , 5:00 p.m. (Pacific
Time) on July 31, 2008.
“ Stock Subscription Agreement
” means the form of Stock Subscription Agreement attached
hereto as Exhibit B .
ARTICLE II
GRANT OF CALL OPTION; SUBSCRIPTION RIGHTS
Section 2.1
Grant of Option . Subject to the terms set forth in
this Agreement, Isis hereby grants to AMI, and AMI hereby acquires
from Isis, an exclusive option, in AMI’s sole discretion (the
“ Call Option ”), to purchase the Optioned Stock
on the terms set forth in this Agreement and in the Acquisition
Agreement.
Section 2.2
Subscription Right . Subject to the terms set forth in
this Agreement, Ibis hereby grants to AMI, and AMI hereby acquires
from Ibis the exclusive right, in AMI’s sole discretion (the
“ Subscription Right ”), to subscribe for and
purchase the Additional Shares on the terms set forth in this
Agreement and in the Stock Subscription Agreement for an aggregate
purchase price of $20,000,000.
Section 2.3
Purchase Price . The “Transaction Value”
for the Optioned Stock shall be equal to (a) either
(i) One Hundred Seventy Five Million and No/100 Dollars
($175,000,000.00) if AMI has exercised the Subscription Right and
acquired the Additional Shares or (ii) One Hundred Ninety Five
Million and No/100 Dollars ($195,000,000.00) if AMI has not
exercised the Subscription Right (the “ Base Purchase
Price ”) plus (b) the Milestone Adjustments (as
defined below), if any.
Section 2.4
Milestone Adjustments . If AMI, in good faith,
determines that the [***] Milestone (as set forth in
Exhibit C hereto) has been reached prior to AMI’s
delivery to Isis of the Option Notice or Isis’ delivery to
AMI of the Purchase Offer Notice (as defined below), as the case
may be, then:
(a) if AMI, in good faith, also
determines that the [***] Milestone (as set forth in
Exhibit C hereto) has been reached as of the date of
the Option Notice or the Purchase Offer Notice, as the case may be,
then the Transaction Value shall be increased by [***] (the “
[***] Milestone Adjustment ”);
(b) if AMI, in good faith, also
determines that the [***] Milestone (as set forth in
Exhibit C hereto) has been reached as of the date of
the Option Notice or the Purchase Offer
2
Notice, as the case may
be, then the Transaction Value shall be increased by [***] (the
“ [***] Milestone Adjustment ”); and
(c) if AMI, in good faith, also
determines that the [***] Milestone (as set forth in
Exhibit C hereto) has been reached as of the date of
the Option Notice or the Purchase Offer Notice, as the case may be,
then the Transaction Value shall be increased by [***] (the “
[***] Milestone Adjustment ” and, together with the
[***] Milestone Adjustment and the [***] Milestone Adjustment, the
“ Milestone Adjustments ”).
The
Milestone Adjustments shall not, under any circumstances, exceed
Fifteen Million and No/100 Dollars ($15,000,000.00) in the
aggregate, and the Transaction Value shall not, under any
circumstances, exceed, in the aggregate (1) One Hundred Ninety
Million and No/100 Dollars ($190,000,000.00) if AMI has exercised
the Subscription Right and acquired the Additional Shares or
(2) Two Hundred Ten Million and No/100 Dollars
($210,000,000.00) if AMI has not exercised the Subscription
Right.
ARTICLE III
EXERCISE OF OPTION
Section 3.1
Exercise of Call Option.
(a) AMI, in its sole discretion
at any time prior to the Call Option Expiration Date, may exercise
the Call Option by executing and delivering to Isis the Option
Notice attached hereto as Exhibit D (the “
Option Notice ”). If AMI exercises the Call
Option in accordance with this Section 3.1 , then in
the Option Notice AMI shall instruct Isis and Ibis to execute and
deliver to AMI, promptly upon receipt of the Option Notice, the
Acquisition Agreement and the Disclosure Schedules thereto (which
shall be the most recent Disclosure Schedules delivered by Isis
pursuant to Section 3.6(a) , unless otherwise agreed to
by the Parties in writing).
(b) If the Disclosure Schedules
attached to the Acquisition Agreement executed and delivered by
Isis and Ibis pursuant to Section 3.1(a) are the
most recent Disclosure Schedules delivered by Isis pursuant to
Section 3.6(a) , then the Call Option shall
automatically expire if AMI, in its sole discretion, does not
execute and deliver the Acquisition Agreement to Isis within five
(5) Business Days after AMI’s receipt of the executed
Acquisition Agreement.
(c) If the Disclosure Schedules
attached to the Acquisition Agreement executed and delivered by
Isis and Ibis pursuant to Section 3.1(a) are not
the most recent Disclosure Schedules delivered by Isis pursuant to
Section 3.6(a) , then the Call Option shall
automatically expire if AMI, in its sole discretion, does not
execute and deliver the Acquisition Agreement to Isis on or prior
to the later of (i) the date that is one month after
AMI’s receipt of the executed Acquisition Agreement and
(ii) the Call Option Expiration Date (which, in this instance,
subject to Section 3.3 and Section 3.4 , is
December 31, 2008).
3
Section 3.2
Exercise of Subscription Right .
(a) AMI, in its sole discretion
at any time prior to the Cut-Off Date, may exercise the
Subscription Right by providing written notice to Isis. If
AMI exercises the Subscription Right in accordance with this
Section 3.2 , then, promptly upon receipt of notice
from AMI, Ibis and Isis shall execute and deliver to AMI the Stock
Subscription Agreement and the Disclosure Schedules thereto (which
shall be the most recent Disclosure Schedules delivered by Isis
pursuant to Section 3.6(a) , unless otherwise agreed to
by the Parties in writing).
(b) If the Disclosure Schedules
attached to the Stock Subscription Agreement executed and delivered
by Isis and Ibis pursuant to Section 3.2(a) are
the most recent Disclosure Schedules delivered by Isis pursuant to
Section 3.6(a) , then the Subscription Right and the
Call Option shall automatically expire if AMI, in its sole
discretion, does not execute and deliver the Stock Subscription
Agreement to Isis within five (5) Business Days after
AMI’s receipt of the executed Stock Subscription
Agreement.
(c) If the Disclosure Schedules
attached to the Stock Subscription Agreement executed and delivered
by Isis and Ibis pursuant to Section 3.2(a) , above are
not the most recent Disclosure Schedules delivered by Isis pursuant
to Section 3.6(a) , then the Subscription Right and the
Call Option shall automatically expire if AMI, in its sole
discretion, does not execute and deliver the Stock Subscription
Agreement and acquire the Additional Shares on or prior to
August 31, 2008.
(d) Subject to
Section 3.2(a) , Section 3.2(b) and
Section 3.2(c) , in the event that Isis or Ibis or any
of their respective Representatives receives a Purchase Offer
within [***] of the Cut-Off Date, then the Cut-Off Date shall be
the Call Acceleration Date.
Section 3.3
Call Option Extension . If the [***] Milestone has not
been met on or before [***], then AMI, in its sole discretion and
without the payment of any additional consideration, may elect to
extend the Call Option Expiration Date to June 30, 2009, by
providing written notice to Ibis at any time prior to
11:59 p.m. (Pacific Time) on [***]
Section 3.4
Call Option Acceleration .
(a) If, during the Call Period,
Isis or Ibis or any of their respective Representatives receives a
Purchase Offer, then Isis shall, within [***] after such receipt,
notify AMI in writing of such Purchase Offer, setting forth in such
notice (the “ Purchase Offer Notice ”) [***] and
indicating therein whether, assuming that the conditions in
Section 3.4(b) have been met, it intends to pursue such
Purchase Offer.
(b) If (i) the Purchase
Offer is from an unaffiliated third party and is unsolicited, bona
fide and in writing, (ii) the [***], (iii) AMI has not
exercised the Call Option, (iv) the consummation of the
Purchase Offer would result in AMI [***] in exchange for the
surrender of the Shares and, if AMI has exercised the Subscription
Right and acquired the Additional Shares, [***] in exchange for the
surrender of the Additional Shares and (v) in such Purchase
Offer Notice, Isis indicates that it desires to pursue the Purchase
Offer, then the Call Option Expiration Date shall accelerate to the
date which is [***] days (the “ Call Acceleration Date
”) from the date on which AMI receives such Purchase Offer
Notice.
4
(c) At any time prior to
5:00 p.m. (Pacific Time) on the Call Acceleration Date, AMI
shall have the right, in its sole discretion, to exercise the Call
Option for either (i) [***], or (ii) [***];
provided that, if AMI, in its sole discretion, elects option
(ii) above, the Acquisition Closing shall be consummated
[***]. If AMI does not exercise the Call Option prior to
5:00 p.m. (Pacific Time) on the Call Acceleration Date, then
the Call Option shall expire.
(d) If Isis or Ibis (as
applicable) fails to consummate the transactions contemplated by
such Purchase Offer on terms no less favorable to Isis or Ibis (as
applicable) than those indicated in the Purchase Offer Notice
within [***] days from the date of the Purchase Offer Notice (the
“ Purchase Offer Termination Date ”), then
(i) Isis and Ibis shall be prohibited from pursuing the
Purchase Offer, (ii) the Call Option shall be reinstated,
(iii) the Call Period shall be extended automatically to the
date that is the later of (A) [***] days after the Purchase
Offer Termination Date and (B) [***] days after the Call
Option Expiration Date (giving effect to any extensions thereof,
but disregarding any acceleration of such date pursuant to
Section 3.4(b) ) and (iv) during the Call Period,
Isis and Ibis shall not be permitted to entertain any subsequent
offers from the third party that submitted such Purchase
Offer.
Section 3.5
Effect of Expiration and Termination of Call Option, Subscription
Right. After (a) the Call Option Expiration Date (subject to
Section 3.4(d) ) or (b) if AMI exercises the Call
Option, (i) the termination of the Acquisition Agreement in
accordance with its terms or (ii) the Acquisition Closing,
(A) this Agreement shall terminate automatically and the Call
Option and Subscription Right shall be null and void and of no
further force or effect without any further action by the Parties
and (B) Isis, Ibis and AMI shall have no further rights or
obligations under this Agreement. Except as expressly set
forth in any Investment Document, the expiration of the Call Period
shall not affect the rights and obligations of any of the parties
hereto and thereto.
Section 3.6
Call Option Exercise and Subscription Right Exercise
Preparation .
(a) AMI may, in connection with
its good faith determination whether to exercise in its sole
discretion the Subscription Right or the Call Option, request that
Isis deliver the Disclosure Schedules to the Stock Subscription
Agreement or the Acquisition Agreement, as the case may be, to AMI
and, thereafter, Isis shall, as soon as reasonably possible,
deliver to AMI the Disclosure Schedules to the Stock Subscription
Agreement or the Acquisition Agreement, as the case may be,
together with a certification of an authorized signatory of Isis
that the representations and warranties set forth in the Stock
Subscription Agreement or the Acquisition Agreement, as the case
may be, as qualified by the Disclosure Schedules, are true and
correct in all respects as of the date of delivery to AMI. In
any event, Isis shall deliver the Disclosure Schedules to the Stock
Subscription Agreement to AMI no later than June 30,
2008.
(b) Isis and Ibis shall
reasonably cooperate with AMI to (i) obtain all necessary
waivers, consents and approvals and (ii) effect all necessary
registrations, filings and submissions that may be required in
connection with the consummation of the transactions contemplated
by the Transaction Documents, including, but not limited to, A)
filings under the Hart Scott Rodino Antitrust Improvements Act of
1976, as amended and any other submissions requested by the Federal
Trade Commission or Department of Justice and (B) such
filings,
5
consents, approvals, orders, registrations and
declarations as may be required under the Laws of any foreign
country.
ARTICLE IV
MISCELLANEOUS PROVISIONS
Section 4.1
Assignment . No Party hereto may assign this Agreement
or its rights and obligations hereunder without the prior written
consent of the other Parties; provided , that AMI may
(i) designate one or more of its Affiliates to exercise the
Call Option or Subscription Right hereunder or to receive title to
the Optioned Stock or Additional Shares by providing written notice
to Ibis at any time prior to the Acquisition Closing or the
acquisition of the Additional Shares and (ii) assign its
rights and obligations hereunder in connection with a Change of
Control of AMI; provided further that Isis may assign its
rights and obligations in connection with a Change of Control of
Isis if such Transfer involves all of the Capital Stock of
Ibis that is owned by Isis and the surviving or acquiring
entity assumes all of Isis’ obligations under the Investment
Documents.
Section 4.2
Notices . All notices or other communications that are
required or permitted under this Agreement will be in writing and
delivered personally with acknowledgement of receipt, sent by
facsimile or other electronic means (and promptly confirmed by
personal delivery, registered or certified mail or overnight
courier as provided herein), sent by nationally-recognized
overnight courier or sent by registered or certified mail, postage
prepaid, return receipt requested, addressed as follows:
|
If to Ibis,
to:
|
|
Ibis Biosciences Inc.
1896 Rutherford Road
Carlsbad, California 92008
Attn: President
Facsimile Number: (760) 603-4653
|
|
|
|
|
|
If to Isis,
to:
|
|
Isis Pharmaceuticals, Inc.
1896 Rutherford Road
Carlsbad, California 92008
Attn: Chief Financial Officer
Facsimile Number: (760) 603-4650
|
|
|
|
|
|
with a copy
to:
|
|
Isis Pharmaceuticals, Inc.
1896 Rutherford Road
Carlsbad, California 92008
Attn: General Counsel
Facsimile Number: (760) 268-4922
|
6
|
If to AMI,
to:
|
|
Abbott Laboratories
Corporate Transactions and Medical Products Legal Operations
Dept. 322, Bldg. AP6A
100 Abbott Park Road
Abbott Park, Illinois 60064-6010
Attn: Vice President and Associate General Counsel
Facsimile Number: (847) 938-1206
|
|
|
|
|
|
with a copy
to:
|
|
Kirkland &
Ellis LLP
200 East Randolph Drive
Chicago, Illinois 60601
Attn:R. Scott Falk, P.C.
Facsimile Number: (312) 861-2200
|
or to such other
address as the Party to whom notice is to be given may have
furnished to the other Parties in writing in accordance
herewith. Any such communication will be deemed to have been
given (i) when delivered on a Business Day, if personally
delivered or sent by facsimile or other electronic means (subject
to confirmation of such delivery), on such Business Day,
(ii) when delivered other than on a Business Day, if
personally delivered or sent by facsimile or other electronic means
(subject to confirmation of such delivery), on the first Business
Day after dispatch, (iii) on the first Business Day after
dispatch, if sent by nationally-recognized overnight courier, and
(iv) on the third Business Day following the date of mailing,
if sent by mail. It is understood and agreed that this
Section 4.2 is not intended to govern the day-to-day
business communications necessary between the Parties in performing
their duties, in due course, under the terms of this
Agreement.
Section 4.3
Counterparts . This Agreement may be executed in any
number of counterparts, each of which will be an original, but all
of which together will constitute one instrument. This
Agreement and any signed agreement or instrument entered into in
connection with this Agreement, and any amendments hereto or
thereto, to the extent signed and delivered by means of a facsimile
machine or other electronic means, shall be treated in all manner
and respects as an original agreement or instrument and shall be
considered to have the same binding legal effect as if it were the
original signed version thereof delivered in person. At the
request of any Party hereto or to any such agreement or instrument,
each other Party hereto or thereto shall re-execute original forms
thereof and deliver them to all other Parties. No Party
hereto or to any such agreement or instrument shall raise the use
of a facsimile machine or other electronic means to deliver a
signature or the fact that any signature or agreement or instrument
was transmitted or communicated through the use of a facsimile
machine or other electronic means as a defense to the formation of
a contract and each such Party forever waives any such defense.
Section 4.4
Amendment . This Agreement may be amended or modified,
and the rights and obligations of the Parties under this Agreement
may be waived, only upon the written consent of each Party.
Section 4.5
Severability . In the event that any provision of this
Agreement, or the application thereof, becomes or is declared by a
court of competent jurisdiction to be illegal, void or
unenforceable, the remainder of this Agreement shall continue in
full force and effect and the
7
application of such
provision to other Persons or circumstances shall be interpreted so
as reasonably to effect the intent of the Parties hereto. The
Parties further agree to replace such void or unenforceable
provision of this Agreement with a valid and enforceable provision
that will achieve, to the extent possible, the economic, business
and other purposes of such void or unenforceable
provision.
Section 4.6
Remedies Cumulative . Except as otherwise provided
herein, any and all remedies herein expressly conferred upon a
Party shall be deemed cumulative with and not exclusive of any
other remedy conferred hereby, or by law or equity upon such Party,
and the exercise by a Party of any one remedy shall not preclude
the exercise of any other remedy.
Section 4.7
Governing Law; Alternative Dispute Resolution . This
Agreement shall be governed by and construed in accordance with the
laws of the State of Delaware without regard to principles of
conflicts of law. The Parties agree that any dispute arising
from or relating to this Agreement shall be exclusively resolved by
the Alternative Dispute Resolution procedures set forth in
Exhibit D to the Master Agreement, the result of which shall
be binding upon the Parties.
Section 4.8
Rules of Construction . The Parties acknowledge
and agree that they have been represented by counsel during the
negotiation, preparation and execution of this Agreement and,
therefore, waive the application of any Law or rule of
construction providing that ambiguities in an agreement or other
document shall be construed against the Party drafting such
agreement or document. Where specific language is used to clarify
by example a general statement contained herein, such specific
language shall not be deemed to modify, limit or restrict in any
manner the construction of the general statement to which it
relates. When the context so requires the word
“or” when used herein shall mean
“and/or.” All pronouns contained herein, and any
variations thereof, will be deemed to refer to the masculine,
feminine or neutral, singular or plural, as the identity of the
Parties may require.
Section 4.9
Further Assurances . Each of the Parties to the
Agreement shall use commercially reasonable efforts to effectuate
the transactions contemplated hereby. Each Party hereto, at
the reasonable request of another Party hereto, shall execute and
deliver such other instruments and do and perform such other acts
and things as may be necessary or desirable for effecting
completely the consummation of this Agreement and the transactions
contemplated hereby.
*
* * * *
[Remainder of
page intentionally left blank; Signatures on following
page]
8
IN
WITNESS WHEREOF, Isis, Ibis and AMI each have caused this Call
Option Agreement to be executed and delivered in their names by
their respective duly authorized officers or
representatives.
|
|
ISIS:
|
|
|
|
|
|
ISIS PHARMACEUTICALS,
INC.
|
|
|
|
|
|
|
|
|
By:
|
/s/ B. Lynne
Parshall
|
|
|
Name:
|
B. Lynne
Parshall
|
|
|
Title:
|
COO &
CFO
|
|
|
|
|
|
|
IBIS:
|
|
|
|
|
|
IBIS BIOSCIENCES,
INC.
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Michael J
Treble
|
|
|
Name:
|
Michael J
Treble
|
|
|
Title:
|
President
|
|
|
|
|
|
|
|
|
|
|
AMI:
|
|
|
|
|
|
|
ABBOTT MOLECULAR
INC.
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Stafford
O’Kelly
|
|
|
Name:
|
Stafford
O’Kelly
|
|
|
Title:
|
President
|
|
|
|
|
|
|
|
|
SIGNATURE PAGE TO CALL OPTION
AGREEMENT
EXHIBIT A
STOCK
PURCHASE AGREEMENT
by and
among
IBIS
BIOSCIENCES, INC.,
ISIS
PHARMACEUTICALS, INC.
and
ABBOTT
MOLECULAR INC.
Dated:
[
,
]
TABLE OF CONTENTS
|
|
|
|
|
Page No.
|
|
|
|
|
|
|
|
Section 1.
|
|
Definitions
|
|
1
|
|
|
|
|
|
|
|
Section 2.
|
|
Basic Transaction; Purchase
Price
|
|
13
|
|
2.1
|
|
Sale and Transfer
of the Remaining Shares
|
|
13
|
|
2.2
|
|
Purchase
Price
|
|
14
|
|
2.3
|
|
Earnout
Payments
|
|
14
|
|
2.4
|
|
Restricted
Assets
|
|
15
|
|
|
|
|
|
|
|
Section 3.
|
|
Closing Of The
Transaction
|
|
16
|
|
3.1
|
|
The
Closing
|
|
16
|
|
3.2
|
|
Deliveries at the
Closing
|
|
16
|
|
|
|
|
|
|
|
Section 4.
|
|
Conditions To Obligation To
Close
|
|
17
|
|
4.1
|
|
Conditions to
Obligation of AMI
|
|
17
|
|
4.2
|
|
Conditions to
Obligation of Isis
|
|
19
|
|
|
|
|
|
|
|
Section 5.
|
|
Representations And
Warranties
|
|
19
|
|
5.1
|
|
Representations
and Warranties of Isis
|
|
19
|
|
5.2
|
|
Representations
And Warranties Of AMI
|
|
36
|
|
|
|
|
|
|
|
Section 6.
|
|
Reserved
|
|
37
|
|
|
|
|
|
|
|
Section 7.
|
|
Pre-Closing
Covenants
|
|
37
|
|
7.1
|
|
General
|
|
37
|
|
7.2
|
|
Affirmative
Covenants of Isis and Ibis
|
|
37
|
|
7.3
|
|
Negative Covenants
of Isis
|
|
38
|
|
7.4
|
|
Notices and
Consents
|
|
40
|
|
7.5
|
|
Full
Access
|
|
40
|
|
7.6
|
|
Transition
Assistance
|
|
40
|
|
7.7
|
|
Notice of
Developments
|
|
41
|
|
7.8
|
|
Exclusivity
|
|
41
|
|
7.9
|
|
Indebtedness and
Intercompany Accounts
|
|
41
|
|
7.10
|
|
Distribution of
Cash and Grants Receivable
|
|
42
|
|
|
|
|
|
|
|
Section 8.
|
|
Additional
Agreements
|
|
42
|
|
8.1
|
|
Survival
|
|
42
|
|
8.2
|
|
Indemnification
|
|
43
|
|
8.3
|
|
Press Release and
Announcements
|
|
45
|
|
8.4
|
|
Expenses
|
|
45
|
|
8.5
|
|
Setoff
|
|
45
|
|
8.6
|
|
Certain Tax
Matters
|
|
46
|
|
8.7
|
|
Further
Assurances
|
|
49
|
|
8.8
|
|
Confidentiality
|
|
50
|
|
8.9
|
|
Noncompetition and
Nonsolicitation
|
|
51
|
i
|
8.10
|
|
Access to Books
and Records
|
|
53
|
|
8.11
|
|
Employee and
Related Matters
|
|
53
|
|
8.12
|
|
Consolidated
Return
|
|
55
|
|
8.13
|
|
Isis Intellectual
Property License
|
|
55
|
|
|
|
|
|
|
|
Section 9.
|
|
Termination
|
|
56
|
|
9.1
|
|
Termination
|
|
56
|
|
9.2
|
|
Effect of
Termination
|
|
56
|
|
|
|
|
|
|
|
Section 10.
|
|
Miscellaneous
|
|
56
|
|
10.1
|
|
No Third Party
Beneficiaries
|
|
56
|
|
10.2
|
|
Entire
Agreement
|
|
56
|
|
10.3
|
|
Successors and
Assigns
|
|
57
|
|
10.4
|
|
Counterparts
|
|
57
|
|
10.5
|
|
Headings
|
|
57
|
|
10.6
|
|
Notices
|
|
57
|
|
10.7
|
|
Governing
Law
|
|
58
|
|
10.8
|
|
Alternative
Dispute Resolution Procedure
|
|
59
|
|
10.9
|
|
Amendments and
Waivers
|
|
59
|
|
10.10
|
|
Delays or
Omissions
|
|
59
|
|
10.11
|
|
Incorporation of
Exhibits and Schedules
|
|
59
|
|
10.12
|
|
Construction
|
|
60
|
|
10.13
|
|
Remedies
|
|
60
|
|
10.14
|
|
Severability
|
|
60
|
|
10.15
|
|
No Other
Compensation
|
|
60
|
ii
STOCK PURCHASE AGREEMENT
THIS STOCK PURCHASE AGREEMENT (this “
Agreement ”) is made and entered into as of this
[ ] day of
[ ,
], by
and among Isis Pharmaceuticals, Inc., a Delaware corporation
(“ Isis ”), Ibis Biosciences, Inc., a
Delaware corporation and majority owned subsidiary of Isis (“
Ibis ”), and Abbott Molecular Inc., a Delaware
corporation (“ AMI ”) and Affiliate of Abbott
Laboratories, an Illinois corporation (“ Abbott
”). AMI, Ibis and Isis are sometimes referred to herein
individually as a “ Party ” and collectively as
the “ Parties .”
WHEREAS, on January 30, 2008, the Parties
entered into the Master Agreement, the Call Option Agreement and
the Investor Rights Agreement, pursuant to which, among other
things, AMI acquired the Shares and the Call Option for an
aggregate purchase price of $20,000,000;
[ WHEREAS, on
[
] , 2008, the Parties entered into the Stock Subscription
Agreement, pursuant to which, among other things, AMI acquired the
Additional Shares for an aggregate purchase price of $20,000,000;
]
WHEREAS, Isis owns 1,000,000 shares of
Ibis’ Common Stock (the “ Remaining Shares
”);
WHEREAS, on
[ ]
[ 200 ], pursuant to the terms of the
Call Option Agreement, AMI exercised the Call Option, electing to
acquire the Remaining Shares pursuant to the terms hereof;
and
WHEREAS, subject to the terms and conditions
set forth in this Agreement, Isis desires to sell to AMI and AMI
desires to acquire from Isis the Remaining Shares.
NOW, THEREFORE, in consideration of the mutual
promises, representations, warranties, and covenants hereinafter
set forth and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the
Parties hereby agree as follows:
Section 1.
DEFINITIONS . Capitalized terms used and not otherwise
defined herein have the meanings ascribed to such terms in this
Section 1 .
(a)
“ Abbott Transaction Team ” means the
individuals listed on Schedule 1(a) .
(b)
[ “ Additional Shares ” means 114,250
shares of Common Stock acquired by AMI pursuant to the Stock
Subscription Agreement, as may be held from time to time by AMI and
its permitted assigns, which, together with the Shares, represent
approximately 18.6% of the issued and outstanding Common
Stock.]
(c)
“ Affiliate ” of an entity means any other
entity that, directly or indirectly, through one or more
intermediaries, controls, is controlled by, or is under common
control with such first entity. For purposes of this
definition only, “control” (and, with correlative
meanings, the terms “controlled by” and “under
common control with”) means the possession, directly or
indirectly, of the power to direct the management or policies of an
entity,
whether through the ownership of voting
securities or by Contract relating to voting rights or corporate
governance; provided , that (i) with respect to AMI and
Abbott, the term “Affiliate” shall specifically exclude
[***] and (ii) with respect to Isis, the term
“Affiliate” shall specifically exclude
[***].
(d)
“ Applicable Law ” or “ Law ”
means all applicable common law, laws, constitutional provisions,
ordinances, statutes, rules, regulations, administrative rulings,
executive orders and other pronouncements having the effect of law
of any federal, national, multinational, state, provincial, county,
city or other political subdivision, agency or other body, domestic
or foreign, including but not limited to any applicable rules,
regulations, guidelines, or other requirements of Governmental
Authorities that may be in effect from time to time.
(e)
“ Applicable Rate ” means as of any particular
date, the prime rate as quoted in the Money Rates Section of
The Wall Street Journal , plus [***]%.
(f)
[***]
(g)
“ Business ” means researching, developing,
manufacturing, selling, marketing, distributing and using a system,
process or reagents for the identification and/or quantitation of
nucleic acids or the performance of services relating to any of the
foregoing, as conducted by Ibis or by Isis, with respect to the
Division, on and prior to the Closing Date.
(h)
“ Business Day ” means any day other than a
Saturday, Sunday, or a day on which the banks in Chicago, Illinois
are authorized or obligated by Law to close.
(i)
“ Call Option ” has the meaning ascribed to such
term in the Call Option Agreement.
(j)
“ Call Option Agreement ” means that certain
Call Option Agreement, dated as of the Investment Date, by and
among Isis, Ibis and AMI.
(k)
“ Capital Stock ” means all capital stock,
equity or controlling interests and other securities in an issuer,
including, without limitation, options, warrants, depositary
receipts, stock appreciation or phantom stock rights or other
agreements or undertakings, including stock or securities
convertible or exchangeable for any shares of capital stock, equity
or controlling interests or other securities in an issuer or
containing any profit participation features or pursuant to which
such issuer is or could be bound to issue or repurchase any capital
stock, equity or controlling interests or other securities.
(l)
“ Change of Control ” means, with respect to any
Person, the occurrence of (i) any consolidation or merger of
such Person with or into any other Person, or any other corporate
reorganization or transaction (including the acquisition of Capital
Stock of such Person (or any rights to acquire, or securities
convertible into or exchangeable for, any such Capital Stock)),
whether or not such Person is a party thereto, in which the
stockholders or equity-holders of such Person or other Persons
controlling such Person immediately prior to such consolidation,
merger, reorganization or transaction, own Capital Stock either
(A) representing directly, or indirectly through one or more
entities, less than fifty percent (50%) of the economic interests
in or voting power of such Person or other surviving entity
immediately after such
2
consolidation, merger, reorganization or
transaction or (B) that does not directly, or indirectly
through one or more entities, have the power to elect a majority of
the entire board of directors or equivalent governing body of such
Person or other surviving entity immediately after such
consolidation, merger, reorganization or transaction or (ii) a
sale, lease, license or other disposition of all or a material
portion of the assets of such Person.
(m)
“ Claim ” means any claim, lawsuit, demand,
audit, investigation, charge, suit, hearing, notice of a violation,
litigation, action, proceeding, order, judgment, grievance, or
arbitration, whether civil, criminal, administrative or otherwise,
whether at law or in equity, or any inquiry likely to result in any
of the foregoing.
(n)
“ Code ” means the Internal Revenue Code of
1986, as amended from time to time.
(o)
“ Common Stock ” means the Common Stock of Ibis,
par value $0.001 per share.
(p)
“ Confidential Information ” means all
information and any tangible embodiments thereof provided by or on
behalf of the Disclosing Party to the Receiving Party or to the
Receiving Party’s Representatives either in connection with
the discussions and negotiations pertaining to the Transaction
Documents or in the course of performing the Transaction Documents,
including without limitation: know-how; data; knowledge; practices;
processes; research and development plans; engineering designs and
drawings; research data; manufacturing processes and techniques;
scientific, manufacturing, marketing and business plans; and
financial and personnel matters relating to the Disclosing Party or
to its present or future products, sales, suppliers, customers,
employees, consultants, independent contractors, investors or
business; regardless of whether any of the foregoing are marked
“confidential” or “proprietary” or
communicated to the other by the Disclosing Party in oral, written,
graphic or electronic form. Notwithstanding the foregoing,
information of a Party will not be deemed Confidential Information
to the extent that the Receiving Party can show by competent proof
that such information:
(i)
is or becomes generally available to the public other than as a
result of an unauthorized disclosure by the Receiving Party or its
Representatives;
(ii)
was available to the Receiving Party or its Representatives on a
non-confidential basis prior to its disclosure by the Disclosing
Party or its Representatives;
(iii)
is or becomes available to the Receiving Party or its
Representatives from a Person, other than the Disclosing Party or
its Representatives, who is not bound by a confidentiality
obligation to the Disclosing Party or its Representatives; or
(iv)
is independently developed by the Receiving Party or its
Representatives without reference to or use of any Confidential
Information of the Disclosing Party.
3
(q)
“ Contract ” means any contract, lease, deed,
mortgage, license, instrument, note, commitment, undertaking,
understanding, indenture, joint venture, purchase order, service
order and all other agreements and arrangements, whether oral or
written.
(r)
“ Contribution Agreement ” means the
Contribution Agreement, dated as of July 31, 2007, by and
between Isis and Ibis.
(s)
“ Corporate Services Agreement ” means that
certain Corporate Services Agreement, dated as of July 31,
2007, by and between Isis and Ibis.
(t)
“ Division ” means the Ibis Biosciences division
of Isis.
(u)
“ Earnout Threshold ” means $150 million minus
all commercial revenue for the period beginning on the date [***]
through the Closing Date as set forth on Schedule 1(u) ,
which has been prepared in accordance with GAAP and Isis’
internal controls and procedures for financial reporting.
(v)
“ Employee Pension Benefit Plan ” has the
meaning set forth in Section 3(2) of ERISA.
(w)
“ Employee Welfare Benefit Plan ” has the
meaning set forth in Section 3(1) of ERISA.
(x)
“ Encumbrance ” means any mortgage, covenant,
hypothecation, condition, Claim, easement, encroachment, right of
way, restriction, option, lien (statutory or otherwise), pledge,
charge, license, security interest or encumbrance of any nature
whatsoever.
(y)
“ Environmental Laws ” means any federal, state,
local or foreign statutes, ordinances, codes, treaties, or other
Laws (including, without limitation, the Comprehensive
Environmental Response, Compensation, and Liability Act, the
Resource Conservation and Recovery Act, the Clean Air Act, the
Clean Water Act, the Toxic Substances Control Act, the Oil
Pollution Prevention Act, the Federal Insecticide,
Fungicide, & Rodenticide Act, the Safe Drinking Water Act,
the Hazardous Materials Transportation Act, the Solid Waste
Disposal Act, the Emergency Planning and Community Right-to-Know
Act, the Occupational Safety and Health Act), including any
regulations, rules, plans, other criteria, policies or guidelines
promulgated pursuant to such Laws, and all common law, orders,
judgments, decrees, judicial or agency interpretations now or
hereafter in effect relating to pollution, the generation,
production, installation, use, storage, treatment, transportation,
Release, threatened Release, investigation, monitoring,
remediation, cleanup, abatement, removal, or disposal of Hazardous
Materials, noise control, odor or the protection of public or
workplace health or safety, natural resources, or the
environment.
(z)
“ ERISA ” means the Employee Retirement Income
Security Act of 1974, as amended.
(aa)
“ Escrow Agent ” means LaSalle Bank National
Association, a national banking association.
4
(bb)
“ Fundamental AMI Representations ” means those
representations and warranties of AMI set forth in Section
5.2(a) (Power and Authority), Section 5.2(b)
(Enforceability), Section 5.2(c) (Governmental Authority;
Consents), and Section 5.2(d) (No Conflicts).
(cc)
“ Fundamental Isis Representations ” means those
representations and warranties of Isis set forth in Sections
5.1(a) (Power and Authority), 5.1(b) (Enforceability),
5.1(c) (Governmental Authority; Consents), 5.1(d) (No
Conflicts), 5.2(e) (Due Organization; Qualification),
5.1(g) (Capitalization; Voting Rights), 5.1(j) (Title
to Properties and Tangible Assets; Liens, etc.), 5.1(k)
(Sufficiency of Assets), 5.1(m) (Compliance with Other
Instruments) and 5.1(v) (Brokers’ Fees).
(dd)
“ GAAP ” means United States generally accepted
accounting principles, applied on a consistent basis.
(ee)
“ Governmental Authority ” means any
governmental or quasi-governmental agency, department, bureau,
office, center, institute, court, commission or other unit of the
government of the United States of America or of any of its
respective States or local units of government thereof, or of a
foreign sovereign or of a provincial, regional or metropolitan
government thereof, including, without limitation, any Regulatory
Authority.
(ff)
“ Grants Receivable ” means (i) any
payments due to Ibis from a Governmental Authority or not for
profit Person with respect to grants awarded to Ibis or Contracts
with Ibis, in each case to the extent Ibis has performed the
research or other services described in the grant or Contract, but
not received payment therefor as of the Closing and (ii) the
rate reserves identified as “Government Rate Reserves”
on Schedule 1(ff) , which has been prepared in accordance
with GAAP and Isis’ internal controls and procedures for
financial reporting.
(gg)
“ Hazardous Materials ” means any substance,
chemical, solvent, compound, waste, residue, contaminant or other
material which is regulated by or forms the basis of liability now
or hereafter under any Environmental Law, including, without
limitation: (i) any “solid waste,”
“dangerous goods,” “hazardous waste,”
“hazardous substance,” “hazardous
material,” “extremely hazardous waste,”
“pollutant,” “contaminant,”
“hazardous constituent,” “special waste,”
“universal waste,” “toxic substance,” or
any other similar term or phrase as defined under any Environmental
Law; (ii) any petroleum, or petroleum products, byproducts or
breakdown products, including crude oil and any fraction thereof;
(iii) natural synthetic gas usable for fuel; (iv) any
asbestos, lead-based paint, polychlorinated biphenyl, mold, radon
gas, radioactive material or byproduct, isomer of dioxin, or any
material or thing containing or composed of such substance or
substances; and (v) any virus, bacteria, protozoa, parasite,
fungi, or other pathogen or any other substance, chemical, solvent,
compound, waste, residue, contaminant or other material which is
hazardous, toxic, poisonous, reactive, corrosive or otherwise may
present a threat to human health, safety, natural resources,
wildlife or the environment.
(hh)
“ Ibis Employee Retention Amount ” means
$[***].
5
(ii)
“ Ibis Net Sales ” means:
(i)
the gross amount billed by Ibis or its Affiliates after the Closing
for the sale or other transfer or disposition of Products to, or
performance of Services for, non-Affiliate third parties in bona
fide arms length transactions, less deductions for:
A.
discounts, including cash discounts, customary trade allowances or
rebates actually taken, and promotional discounts;
B.
credits or allowances given or made for rejection, recall or return
of previously sold Products and rebates for previously provided
Services;
C.
any Tax (including any Tax such as a value added or similar Tax)
levied on the sale, transportation or delivery of Products when
included on the invoice or other written document between the
parties as payable by the purchaser and collectable by Ibis;
and
D.
freight, postage, transportation, insurance and duties on shipment
of Product when included on the invoice or written document between
the parties as payable by the purchaser and collectable by
Ibis;
(ii)
[***]; and
(iii)
the amount of any [***].
Ibis Net Sales
calculations shall be applied as provided above and modified as
appropriate as follows:
1.
When a Product is sold or licensed by Ibis or its Affiliates or a
Service is provided to a non-Affiliate third party with whom Ibis
or such Affiliate does not deal at arms length, Ibis Net Sales for
that Product or Service shall equal an average of Ibis Net Sales
for similar quantities of Products sold or Services provided within
the same calendar quarter in an arms length transaction in the same
geographic market and class of purchasers or Service
recipients as the non-arms length purchaser or Service
recipient.
2.
In the event that a Product is sold or a Service provided in
combination with any other product(s) or service(s), Ibis Net
Sales with respect to the Product or Service of the combination
shall be determined by the fraction A over A + B in which
“A” is Ibis Net Sales of the Product or Service portion
of the combination when sold separately during the applicable
calendar quarter, and “B” is Ibis Net Sales of the
other product(s) or service(s) of the combination product
or service when sold separately during the applicable calendar
quarter.
3.
In the event a Product or Service is incorporated into a profile in
which said Product or Service contributes only a small proportion
of the value of the total package, but the adjustment set forth in
paragraph 2, above is impractical or if similar quantities of
product(s) are not sold or similar quantities of Services are
not provided pursuant to paragraph 1, above, then the
Parties
6
shall negotiate in good faith to establish an
equitable adjustment to Ibis Net Sales for such Product or Service
to fairly reflect the proportion of the value of the profile
contributed by the Product or Service or the value of the Product
or Service.
(jj)
“ Indebtedness ” means (i) all indebtedness
or other obligations of Ibis for borrowed money, whether current,
short-term or long-term, secured or unsecured, and all accrued
interest, premiums, penalties and other obligations relating
thereto, (ii) all indebtedness of Ibis for the deferred
purchase price of property or services which is not evidenced by
accounts payable incurred in the ordinary course of business,
(iii) all existing lease obligations of Ibis under leases
which are capital leases in accordance with GAAP, (iv) any
liability of Ibis under deferred compensation plans, phantom stock
plans, severance or bonus plans, or any change in control or
similar payment or increased cost which is triggered or made or
will be made payable by Ibis as a result of the transactions
contemplated hereby, other than the Permitted Employee Compensation
Plan, (v) any off balance sheet financing of Ibis,
(vi) any payment obligations of Ibis in respect of
banker’s acceptances or letters of credit, (vii) any
liability of Ibis with respect to interest rate swaps, collars,
caps and similar hedging obligations, (viii) all obligations
of Ibis arising under or with respect to any conditional sale or
other title retention agreement with respect to property acquired
by Ibis, (ix) past due or deferred rent of Ibis, (x) the
amount of accounts payable owed by Ibis to any Person that have not
been paid within 45 days of the date of invoice thereof (xi) all
“cut” but “uncashed” checks of Ibis
outstanding as of the Closing, (xii) any indebtedness referred to
above of any Person which is either guaranteed by, or secured by a
security interest upon any property owned by, Ibis and (xiii)
accrued and unpaid interest of, and prepayment premiums, penalties
or similar contractual charges arising as a result of the discharge
of any such foregoing obligation.
(kk)
“ Intellectual Property ” means all of the
following in any jurisdiction throughout the world:
(i) patents, patent applications and patent disclosures
and statutory invention registrations, including reissues,
divisions, continuations, continuations in part, extensions and
reexaminations thereof; (ii) trademarks, service marks, trade
dress, trade names, corporate names, logos and slogans (and all
translations, adaptations, derivations and combinations of the
foregoing) and Internet domain names any and all common law rights
and registrations and applications for the registration thereof,
and all extensions and renewals of any of the foregoing;
(iii) copyrights and copyrightable works (including Software),
registered copyrights and copyright applications, mask works, net
lists and schematics; (iv) confidential and proprietary
information including technology, know-how, trade secrets,
unpatented inventions, ideas, algorithms and processes (including,
without limitation, manufacturing and production processes and
techniques, drawings, specifications, designs, plans, proposals,
test data including pharmacological, biological, chemical,
biochemical, toxicological and clinical test data, analytical and
quality control data, stability data and customer and supplier
lists and related information); (v) other intellectual
property and proprietary information and (vi) all copies and
tangible embodiments of the foregoing, such as instruction manuals,
laboratory notebooks, prototypes, samples, specimens, studies and
summaries.
(ll)
“ Investment Date ” means January 23,
2008.
(mm)
“ Investment Documents ” means the Master
Agreement, the Call Option Agreement, the Investor Rights Agreement
[ and the Stock Subscription Agreement ] .
7
(nn)
“ Investor Rights Agreement ” means that certain
Investor Rights Agreement, dated as of the Investment Date, by and
among Isis, Ibis and AMI.
(oo)
“ Isis Licensed Intellectual Property ” means
the Intellectual Property set forth on Schedule 1(qq)
.(1)
(pp)
[***]
(qq)
“ Knowledge ” and terms of similar meaning
(including, without limitation, “is aware of”) mean (i)
with respect to Ibis and Isis, the actual knowledge of any of the
individuals set forth on Schedule 1(qq) , after due
investigation, including, without limitation, inquiry of Persons
with subject matter knowledge, provided that (A) solely for
purposes of Sections 5.1(l)(v) , 5.1(l)(vi) and
5.1(l)(ix) , “Knowledge” and terms of similar
meaning (including, without limitation, “is aware of”)
mean the actual knowledge of any employee of Ibis or Isis, after
due investigation, including, without limitation, inquiry of
Persons with subject matter knowledge and (B) solely for
purposes of Section 5.1(l) , inquiry of Persons with subject
matter knowledge shall include inquiry of the outside counsel
involved in the development or prosecution of the Business IP or
who conducted ‘freedom to operate analyses’ identified
on Schedule 1(qq) and (ii) with respect to AMI, the actual
knowledge of any of the individuals set forth on Schedule
1(qq) , after due investigation.
(rr)
“ Licenses ” means all licenses, permits,
certificates of authority, variances, authorizations, approvals,
registrations, franchises, orders and similar consents issued
by any Governmental Authority or other Person, provided that the
term License shall not include any license or other right to use
any Intellectual Property.
(ss)
“ Loss ” means any loss, liability, demand,
Claim, action, cause of action, cost, damage, diminution in value,
deficiency, Tax, penalty, fine or expense (including interest,
penalties, reasonable attorneys’ fees and expenses and all
amounts paid in investigation, defense or settlement of any of the
foregoing and the enforcement of any related rights), whether or
not arising out of third party claims.
(tt)
“ Management Presentations ” means the
Management Presentations of Ibis delivered to AMI pursuant to
Section 2(h) of the Master Agreement.
(uu)
“ Master Agreement ” means that certain
Strategic Alliance Master Agreement, dated as of the Investment
Date, by and among Isis, Ibis and AMI.
(vv)
“ Multiemployer Plan ” has the meaning set forth
in Section 3(37) of ERISA.
(ww)
“ Offering Memorandum ” means the Offering
Memorandum of Ibis, dated November 2006 as made available to
AMI.
(1) This will be the Isis Intellectual
Property that Ibis Employees have identified as being useful to the
Business.
8
(xx)
[***] means any payments, including, but not limited to royalty
payments, license fees and milestone payments that are made by
non-Affiliate third parties to [***](or any of its Affiliates) in
bona fide arms length transactions in consideration for one or more
license or equivalent agreements that grant such non-Affiliate
third party rights under any [***](i) make, have made, use,
sell, offer for sale or import any products [***]to another party
for a fee, in each case, where any of the foregoing conduct by such
non-Affiliate third party in the absence of such rights under
license or equivalent agreement would infringe (directly,
contributorily, by inducement or otherwise), misappropriate or
otherwise conflict with any [***]
(yy)
“ Permitted Employee Compensation Plan ” means
the compensation plan mutually agreed by the Parties regarding the
[***] the terms of which are described on Exhibit D
attached hereto.
(zz)
“ Permitted Encumbrances ” means (i) liens
for current property Taxes not yet due and payable,
(ii) Encumbrances arising in connection with and solely as a
result of Permitted Indebtedness and (iii) except with respect
to Intellectual Property, other imperfections of title,
restrictions or Encumbrances, if any, which imperfections,
restrictions or Encumbrances do not, individually or in the
aggregate, impair the continued use and operation of the assets
used in the operation of the Business and do not affect the
merchantability of the title to such assets to which they
relate.
(aaa)
“ Permitted Indebtedness ” means
(i) accounts payable incurred in the ordinary course of
business that are paid within forty-five (45) days of the date of
invoice thereof, (ii) Indebtedness arising from existing and
future lease obligations of Ibis under equipment leases that are
capital leases in accordance with GAAP so long as the collateral
for such capital leases is limited to the equipment acquired and
the aggregate amount of such capital leases does not exceed $[***]
and (iii) Indebtedness incurred pursuant to the Corporate
Services Agreement or the Contribution Agreement.
(bbb) “
Person ” means an individual, a partnership, a
corporation, an association, a limited liability company, a joint
stock company, a trust, a joint venture, an unincorporated
organization, or a Governmental Authority (or any department,
agency, or political subdivision thereof).
(ccc)
“ Pre-Closing Tax Period ” means a Tax period
ending on or before the Closing Date and the portion through the
end of the Closing Date for any Tax period that includes (but does
not end on) the Closing Date.
(ddd) “
Post-Closing Tax Period ” means a Tax period beginning
after the Closing Date and, for any Tax period that includes (but
does not end on) the Closing Date, the portion of such period
beginning after the Closing Date.
(eee)
“ Products ” means the T5000 Biosensor System
(including kits) and any Successor Products.
(fff)
“ Purchase Offer ” means any proposal or offer
from any Person (other than AMI and its Affiliates in connection
with the transactions contemplated hereby) or any agreement or
offer relating to any (i) reorganization, liquidation,
dissolution, share exchange,
9
business combination or
recapitalization of Ibis, (ii) merger or consolidation
involving Ibis, (iii) purchase or sale of any assets or
Capital Stock of Ibis (other than the purchase and sale of
inventory and capital equipment in the ordinary course of
business), (iv) distribution of Ibis’ existing or future
products, (v) licensing of any Business IP from Ibis or
(vi) any other transaction or business combination involving
Ibis or its business or assets which would reasonably be expected
to interfere with, impede or materially delay the transactions
contemplated by the Transaction Documents or dilute the benefits
thereof to AMI and its Affiliates.
(ggg) “
Real Property ” means the Leased Real Property.
(hhh) “
Regulatory Authority ” means any Governmental
Authority that has responsibility for granting any licenses or
approvals or granting pricing and/or reimbursement approvals
necessary for the marketing and sale of medical devices or
diagnostic products, including without limitation, the FDA, the
European Medicines Agency and the United States Department of
Health and Human Services.
(iii)
“ Release ” means any spilling, leaking,
pumping, pouring, emitting, emptying, discharging, injecting,
escaping, leaching, dumping, depositing, disposing or other release
into the environment (including the abandonment or discarding of
barrels, drums, containers or other closed receptacles), including
any dispersal, migration or other movement of any substance through
or in air, soil, surface water, groundwater or property.
(jjj)
“ Representatives ” means with respect to any
Person, such Person’s employees, directors, officers,
Affiliates and authorized agents.
(kkk)
“ Schedule ” means any of the Disclosure
Schedules delivered to AMI herewith and incorporated herein
pursuant to Section 10.11 hereof.
(lll)
“ SEC ” or “ Commission ”
means the United States Securities and Exchange Commission.
(mmm) “ Securities
Act ” means the Securities Act of 1933, as amended.
(nnn) “
Services ” means using any Business IP to analyze
samples containing nucleic acids and providing the results of such
analyses to a third party for a fee.
(ooo) “
Shares ” means 114,251 shares of Common Stock issued
to AMI pursuant to the Master Agreement, as may be held from time
to time by AMI and its permitted assigns, representing
approximately 10.25% of the issued and outstanding Common
Stock.
(ppp) “
Software ” means any and all (i) computer
programs, libraries, firmware and middleware, including any and all
software implementations of algorithms, models and methodologies,
whether in source code or object code, (ii) databases and
compilations, including any and all data and collections of data,
whether machine readable or otherwise, (iii) descriptions,
flow-charts and other work product used to design, plan, organize
and develop any of the foregoing and (iv) all programmer and
user documentation, including user manuals and training materials,
relating to any of the foregoing.
10
(qqq) [
“ Stock Subscription Agreement ” means the Stock
Subscription Agreement dated as of
[ ]
, 2008, by and among Ibis, Isis and AMI. ]
(rrr)
“ Subsidiary ” means, with respect to a Person,
any corporation, limited liability company, partnership,
association or other business entity of which (i) if a
corporation, a majority of the total voting power of shares of
stock entitled (without regard to the occurrence of any
contingency) to vote in the election of directors, managers or
trustees thereof is at the time owned or controlled, directly or
indirectly, by such Person or one or more of the other Subsidiaries
of such Person or a combination thereof, or (ii) if a limited
liability company, partnership, association or other business
entity, a majority of the partnership or other similar ownership
interest thereof is at the time owned or controlled, directly or
indirectly, by such Person or one or more Subsidiaries of such
Person or a combination thereof. For purposes hereof, a
Person shall be deemed to have a majority ownership interest in a
limited liability company, partnership, association or other
business entity if such Person shall be allocated a majority of
limited liability company, partnership, association or other
business entity gains or losses or shall be or control any managing
director or general partner of such limited liability company,
partnership, association or other business entity.
(sss)
“Successor Products” means any product that
(i) relies upon [***] and determination of [***] by [***]
using either the Ibis [***], each as in existence in the Business
at the Closing, including as may be modified subsequently by AMI or
(ii) is described in U.S. Patent No.’s [***].
(ttt)
“ T5000 Biosensor System ” means the biosensor
platform generally known as the T5000 Biosensor System, together
with all equipment, hardware, Software, systems and other materials
required for its use, or provided or recommended by Ibis, Isis or
any of their respective Affiliates for its use, as well as all
prior versions of the T5000 Biosensor System, including such
systems known as “TIGER.”
(uuu) “
Tax ” means any federal, state, local, or foreign
income, gross receipts, license, payroll, employment, excise,
severance, stamp, occupation, premium, windfall profits,
environmental, customs and other duties, capital stock, franchise,
profits, withholding, social security, unemployment, disability,
real property, personal property, sales, use, transfer,
registration, value added, alternative or add-on minimum,
estimated, or other tax of any kind whatsoever, including any
interest, penalty, or addition thereto, whether disputed or not,
and including any obligation to indemnify or otherwise assume or
succeed to the Tax liability of any other Person.
(vvv) “
Tax Return ” means any return, declaration, report,
claim for refund, or information return or statement relating to
Taxes, including any schedule or attachment thereto, and including
any amendment thereof.
(www) “ Third Party
Payments ” means payments, including, but not limited to
damage awards, royalty payments, license fees and milestone
payments, that are made by[***]to a third party, which are based
upon making, having made, using, selling, offering for sale or
importing [***]under order of a Governmental Authority or license
agreements or equivalent agreements with the third party to obtain
rights under any United States or foreign
11
copyrights, patent applications or
patents that are [***]to make, have made, use, sell, offer for sale
or import any [***]
(xxx)
“ Transaction Documents ” means the Master
Agreement, the Investor Rights Agreement, [ the Stock
Subscription Agreement, ] the Call Option Agreement, the
Transition Services Agreement, the Escrow Agreement and this
Agreement.
(yyy) “
Transfer ” means, with respect to Capital Stock, any
sale, pledge, hypothecation, assignment, Encumbrance or other
transfer or disposition, whether directly, indirectly, voluntarily,
involuntarily, by operation of Law, pursuant to judicial process or
otherwise and, when the context so requires, the act of doing any
of the foregoing.
Section references for definitions of
defined terms defined in the body of this Agreement rather than in
this Section 1 .
|
Defined Term
|
|
Section
|
|
“§ 338(h)(10)
Election”
|
|
8.6(g)
|
|
“Abbott”
|
|
Preamble
|
|
“ADR”
|
|
10.8
|
|
“Agreement”
|
|
Preamble
|
|
“AMI”
|
|
Preamble
|
|
“AMI Group”
|
|
8.2(a)
|
|
“AMI Proceeding”
|
|
8.6(e)(ii)
|
|
“Applicable AMI
Proceeding”
|
|
8.6(e)(ii)
|
|
“Closing”
|
|
3.1
|
|
“Closing Date”
|
|
3.1
|
|
“Closing Purchase Price”
|
|
2.2
|
|
“Disclosing Party”
|
|
8.8(a)
|
|
“Disclosure Schedules”
|
|
Section 5
|
|
“Earnout Payments”
|
|
2.3(e)
|
|
“Earnout Period”
|
|
2.3(a)
|
|
“Escrow Agreement”
|
|
4.1(l)
|
|
“Financial Statements”
|
|
5.1(t)
|
|
“Foreign Person”
|
|
4.1(m)
|
|
“Government Contracts”
|
|
5.1(l)(ii)
|
|
“HSR Act”
|
|
4.1(d)
|
|
“Ibis”
|
|
Preamble
|
12
|
“Ibis Contracts”
|
|
5.1(x)(i)
|
|
“Ibis Employees”
|
|
8.11(a)
|
|
“Indemnified Party”
|
|
8.2(e)
|
|
“Indemnifying Party”
|
|
8.2(e)
|
|
“Isis”
|
|
Preamble
|
|
“Isis Proceeding”
|
|
8.6(e)(i)
|
|
“Isis Retirement Plans”
|
|
8.11(d)
|
|
“Leased Real Property”
|
|
5.1(w)(ii)
|
|
“Leasehold Improvements”
|
|
5.1(w)(ii)
|
|
“Leases”
|
|
5.1(w)(ii)
|
|
“Material Adverse
Effect”
|
|
4.1(j)
|
|
“Material Licenses”
|
|
5.1(q)(ii)
|
|
“Noncompete Period”
|
|
8.9(a)
|
|
“Nonsolicitation Period”
|
|
8.9(c)
|
|
“Parties”
|
|
Preamble
|
|
“Party”
|
|
Preamble
|
|
“Purchase Price”
|
|
2.2
|
|
“Receiving Party”
|
|
8.8(a)
|
|
“Remaining Shares”
|
|
Recitals
|
|
“Restricted Assets”
|
|
2.4
|
|
“Seller Group”
|
|
8.2(b)
|
|
“Straddle Period”
|
|
8.6(c)(ii)
|
|
“Third Party Claim”
|
|
8.2(e)
|
|
“Transaction Value”
|
|
2.2
|
|
“Transition Services
Agreement”
|
|
4.1(k)
|
|
“WARN Act”
|
|
8.11(b)
|
Section 2.
BASIC TRANSACTION; PURCHASE PRICE .
2.1
Sale and Transfer of the Remaining Shares . Subject to
the terms and conditions of this Agreement, at the Closing, Isis
shall sell, convey, assign, transfer and deliver to AMI all of the
Remaining Shares, free and clear of all Encumbrances, and AMI shall
purchase, acquire and accept the Remaining Shares from Isis.
13
2.2
Purchase Price . The purchase price (the “
Purchase Price ”) for the Remaining Shares shall be
equal to
(i) $[ ](2) (the
“ Transaction Value ”), minus (ii) the
amount of any Indebtedness of Ibis as of the Closing (not including
the amount of any Indebtedness that is Permitted Indebtedness under
clauses (i) or (ii) of the Permitted Indebtedness
definition), minus (iii) the Ibis Employee Retention Amount,
plus (iv) the Earnout Payments. The “ Closing
Purchase Price ” is an amount equal to (x) the
Transaction Value, minus (y) the amount of any Indebtedness of
Ibis as of the Closing (not including the amount of any
Indebtedness that is Permitted Indebtedness under clauses
(i) or (ii) of the Permitted Indebtedness definition),
minus (z) the Ibis Employee Retention Amount.
2.3
Earnout Payments .
(a)
Subject to Sections 2.3(e) and 2.3(f) , from
and after the Closing Date until December 31, 2025 (the
“ Earnout Period ”), Ibis will pay to Isis an
amount equal to five percent (5%) (the “ Earnout Rate
”) of cumulative Ibis Net Sales that are (i) in excess
of the Earnout Threshold and (ii) less than or equal to $2.1
billion. Such amounts payable to Isis will be reduced by an
amount equal to [***]% of any [***], but in no event will such
amounts for such Ibis Net Sales be less than two and a half percent
(2.5%) of such cumulative Ibis Net Sales.
(b)
For cumulative Ibis Net Sales that are in excess of $2.1 billion,
the Earnout Rate will reduce from 5% to 3%. The corresponding
amounts payable to Isis will be reduced by an amount equal to
[***]% of any [***], but in no event will such amounts for such
Ibis Net Sales be less than one and a half percent (1.5%) of such
cumulative Ibis Net Sales.
(c)
In calculating the amount of any reduction to the earn-out payments
permitted by the second sentence of either
Section 2.3(a) or Section 2.3(b)
that result from any [***] that are [***], the amount of such
[***] will be [***] of the Earnout Period from the date of such
[***]. For example, if Ibis makes a [***] in the form of
[***] equal to [***] to [***] which, in AMI’s reasonable
judgment was [***] and such [***] was made in 2015, then, in each
calendar quarter, Ibis would be able to reduce the corresponding
amounts payable for such quarter by [***], in each case subject to
the applicable 2.5% or 1.5% floor under Section 2.3(a)
or Section 2.3(b) .
(d)
The earnout amounts described in Sections 2.3(a) and
2.3(b) will be payable on a quarterly basis, within
[***] days after the last day of each calendar quarter, by wire
transfer of immediately available funds to an account designated by
Isis. Within [***] days of the end of each calendar quarter,
Ibis will deliver to Isis its non-binding, preliminary, good faith
estimate of Ibis Net Sales for such calendar quarter. All
amounts included in Ibis Net Sales shall be in United States funds
collectible at par in Chicago, Illinois. With respect to
product or service revenues, [***], or [***] that are used in the
calculation of Ibis Net Sales and are in monies other than United
States dollars, the amount to be used will first be determined in
the foreign currency of the country for such monies and then
converted into equivalent United States
(2) The
Transaction Value from the Option Notice to be inserted
here.
14
funds using the same
conversion methodology that Abbott uses to prepare its financial
statements filed with the SEC.
(e)
Notwithstanding the foregoing, Sections 2.3(a) through
2.3(c) , (i) the earnout amounts described in
Sections 2.3(a) and 2.3(b) will be
payable only on cumulative Ibis Net Sales in excess of the Earnout
Threshold, (ii) no such earnout amounts will be payable in any
calendar year in which total Ibis Net Sales in such calendar year
were less than or equal to $[***] million, (iii) in any
calendar year in which Ibis Net Sales exceed $[***] million and
cumulative Ibis Net Sales exceed the Earnout Threshold, the earnout
amounts described in Sections 2.3(a) and
2.3(b) will be payable with respect to all Ibis
Net Sales in such calendar year which are in excess of the Earnout
Threshold and (iv) all Ibis Net Sales, regardless of whether
earnout amounts are payable thereon, will be included in cumulative
Ibis Net Sales for purposes of determining the applicable Earnout
Rate. For example, if Ibis Net Sales in each of the calendar
years 1 and 3 are equal to $[***] million and Ibis Net Sales in
each of the calendar years 2 and 4 are equal to $[***] million, no
earnout amounts would be payable in calendar years 1 through 3, but
earnout amounts would be payable with respect to the entire $[***]
million in Ibis Net Sales in calendar year 4. The earnout
amounts payable by Ibis to Isis pursuant to this
Section 2.3 are referred to herein as the “
Earnout Payments .”
(f)
Ibis shall maintain its books and records used to determine Ibis
Net Sales, [***], and [***] for a period of three (3) years
from the date of the Earnout Payment to which they pertain.
Ibis shall make such books and records available for inspection by
third party representatives of Isis approved in writing (which
approval shall not be unreasonably withheld, conditioned or
delayed) once per calendar year at reasonable times and upon
reasonable written advance notice from Isis. All information
contained in these books and records shall be Confidential
Information and will be used only for the purpose of determining
the accuracy of Ibis’ calculation of any Earnout
Payment.
(g)
Notwithstanding any provision of this Agreement or any other
Transaction Document, except with respect to any [***] arising as a
result of or in connection with a breach of the representations and
warranties set forth in Section 5.1(l)(v) , the Earnout
Payment reductions set forth in Sections 2.3(a) and
2.3(b) will be the AMI Group’s sole and
exclusive remedy for any [***].
2.4
Restricted Assets. Notwithstanding any other
provision in this Agreement to the contrary, this Agreement shall
not constitute an agreement to assign or transfer any interest in
any Contract, asset, claim, right or benefit the assignment or
transfer of which is otherwise contemplated by the transactions
contemplated by this Agreement to the extent such assignment or
transfer (or attempt to make such an assignment or transfer)
without the consent or approval of a third party would constitute a
breach or other contravention of the rights of such third party, or
affect adversely the rights of any Party or their Affiliates
thereunder (such assets being collectively referred to herein as
“ Restricted Assets ”). Any assignment or
transfer of a Restricted Asset shall be made subject to such
consent or approval being obtained. If any such consent or
approval is not obtained prior to the Closing, (i) the
assigning or transferring Party shall continue to use its
commercially reasonable efforts to cooperate with the other Party
in attempting to obtain any such consent or approval and
(ii) establish alternative arrangements (such as a license,
sublease, subcontract or operating agreement) until such time as
such consent
15
or approval has been
obtained which results in the assignee or transferee Party
receiving all the benefits and bearing all the burdens with respect
to any such Restricted Asset (subject to Section 8.4 ,
pursuant to which Isis shall be liable for and pay all
out-of-pocket costs and expenses associated with obtaining third
party consents associated with any Ibis Contract or Restricted
Asset in excess of $[***] in the aggregate).
Section
3.
CLOSING OF THE TRANSACTION .
3.1
The Closing . Subject to the satisfaction or waiver of
the conditions set forth herein, the closing of the transactions
contemplated by this Agreement (the “ Closing ”)
shall take place at the offices of Kirkland & Ellis LLP in
Chicago, Illinois, at 10:00 a.m. local time on or before the
third Business Day following the satisfaction or waiver of all
conditions to the obligations of the Parties to consummate the
transactions contemplated herein, or such other time and place as
the Parties may mutually determine (the “ Closing Date
”), and the Closing shall be deemed effective as of
12:01 a.m. local time on the Closing Date.
3.2
Deliveries at the Closing . At the Closing:
(a)
Isis shall deliver to AMI (i) the various certificates,
agreements, instruments and documents referred to in
Section 4.1 below and (ii) such other instruments
of sale, transfer, conveyance and assignment as AMI reasonably may
request;
(b)
AMI shall deliver to Isis (i) the Closing Purchase Price, via
wire transfer of immediately available funds to an account
designated in writing by Isis at least five (5) Business Days
prior to the Closing Date, and (ii) the various certificates,
agreements, instruments and documents referred to in
Section 4.2 below;
(c)
AMI shall deliver to the Escrow Agent the Ibis Employee Retention
Amount, via wire transfer of immediately available funds to an
account designated by the Escrow Agent, to be held in escrow
pursuant to the terms of the Escrow Agreement;
(d)
Isis shall deliver to Ibis all books, records and other materials
of Ibis or related to or used by Ibis in the Business (unless
otherwise specifically set forth in the Transition Services
Agreement);
(e)
Isis shall deliver to AMI the Permitted Employee Compensation Plan;
and
(f)
Isis shall deliver to AMI one or more compact discs or other
electronic media containing the contents of the electronic dataroom
maintained by Isis at [***] as of the date that is three Business
Days prior to the date hereof, together with a certificate of an
authorized officer certifying that such compact discs contain true,
accurate and complete copies of the materials in such dataroom as
of such date.
16
Section
4.
CONDITIONS TO OBLIGATION TO CLOSE.
4.1
Conditions to Obligation of AMI . The obligation of
AMI to consummate the transactions to be performed by it in
connection with the Closing is subject to satisfaction of the
following conditions:
(a)
The representations and warranties of Isis set forth in this
Agreement shall be true and correct in all material respects at and
as of the date hereof and as of the Closing Date (disregarding any
materiality or Material Adverse Effect qualifications contained
therein); provided, that any representation or warranty of Isis set
forth in this Agreement that is made as of any date other than the
date hereof shall be true and correct as of such date in all
material respects (disregarding any materiality or Material Adverse
Effect qualifications contained therein).
(b)
Each of Isis and Ibis shall have performed and complied in all
material respects with all of their covenants hereunder through the
Closing.
(c)
No Claim shall be pending before any court, arbitrator, other body
or administrative agency of any Governmental Authority wherein an
unfavorable injunction, judgment, order, decree, ruling or charge
would prevent consummation of any of the transactions contemplated
by this Agreement (and no such injunction, judgment, order, decree,
ruling or charge shall be in effect).
(d)
All filings with and authorizations and approvals of Governmental
Authorities that are required for the consummation of the
transactions contemplated hereby shall have been duly made and
obtained on terms reasonably satisfactory to AMI. Without
limiting the generality of the foregoing, all applicable waiting
periods (and any extensions thereof) under the Hart Scott Rodino
Antitrust Improvements Act of 1976, as amended (the “ HSR
Act ”), shall have expired or otherwise been
terminated.
(e)
Isis shall have delivered to AMI (i) a certificate from an
officer of Isis to the effect that each of the conditions specified
in Section 4.1(a) , Section 4.1(b)
and Section 4.1(j) is satisfied in all
respects, (ii) a copy of the resolutions of the governing body
of each of Isis and Ibis approving the transactions contemplated by
this Agreement, certified by an officer of each of Isis and Ibis,
respectively, (iii) certificates from appropriate authorities,
dated as of or about the Closing Date, as to the good standing and
qualification to do business of Ibis in its jurisdiction of
incorporation, (iv) such other documents or instruments as are
required to be delivered at the Closing pursuant to the terms
hereof and (v) such other documents or instruments as AMI
reasonably requests to effect the transactions contemplated
hereby.
(f)
Isis shall tender to AMI a certificate representing the Remaining
Shares duly and validly endorsed for transfer in favor of AMI or
accompanied by a separate stock power duly and validly executed by
Isis and otherwise sufficient to vest in AMI legal and beneficial
ownership of the Remaining Shares.
(g)
Isis shall have received and delivered to AMI all third party
consents identified on Schedule 4.1(g) and Isis and AMI
shall have received all other
17
authorizations, consents, and approvals of
Governmental Authorities referred to in Sections 5.1(c)
and 5.1(d) .
(h)
Ibis shall have the benefit of all Licenses necessary to conduct
the Business as it had been conducted prior to the Closing and as
contemplated to be conducted immediately thereafter.
(i)
Isis shall have obtained (A) payoff letters for any
Indebtedness of Ibis to be paid by AMI on behalf of Isis at the
Closing and (B) releases of any and all Encumbrances on the
Remaining Shares or the assets of Ibis (except, with respect to the
assets of Ibis, Permitted Encumbrances), all on terms reasonably
satisfactory to AMI.
(j)
Since the Investment Date, there shall have been no occurrence or
disclosure of any event, circumstance or state of facts which has,
or would reasonably be expected to have, a material adverse effect
on the business, assets, condition (financial or otherwise),
operations, operating results, employee relations, customer
relations or supplier relations of Ibis (a “ Material
Adverse Effect ”).
(k)
Isis and Ibis shall have executed and delivered to AMI the
Transition Services Agreement substantially in the form attached
hereto as Exhibit A (the “ Transition Services
Agreement ”) and the Transition Services Agreement shall
be in full force and effect.
(l)
Isis shall have executed and delivered to AMI an escrow agreement
substantially in the form attached hereto as Exhibit B
(the “ Escrow Agreement ”) and the Escrow
Agreement shall be in full force and effect.
(m)
Isis shall have executed and delivered to AMI a non-foreign
affidavit dated as of the Closing Date and in form and substance
required under the Treasury Regulations issued pursuant to
Section 1445 of the Internal Revenue Code stating that Isis is
not a “Foreign Person” as defined in Code §
1445.
(n)
There shall not have been any material breach of any of the terms
and provisions of the Transaction Documents that has not been
waived by AMI.
(o)
Except as contemplated by Section 2.4 and the
Transition Services Agreement, Ibis shall be entitled to fully
exercise without restriction or limitation all legal and beneficial
rights under the Ibis Contracts (including the Government
Contracts) and all other assets, properties and rights related to,
used in or necessary to operate and conduct the Business in all
respects in the manner conducted on and prior to the Closing Date
and as contemplated to be conducted from and after the Closing
Date.
(p)
[***].
AMI may waive any
condition specified in this Section 4.1 if it executes
a writing so stating at or prior to the Closing. In the event
of any such waiver, AMI shall be deemed to have waived any claim
against Isis for failure to satisfy such condition; provided
that, except to the extent specifically and expressly set forth in
such waiver, any such waiver shall not limit
18
AMI’s right to
recovery hereunder for a breach by either Isis or Ibis of any other
provision of this Agreement.
4.2
Conditions to Obligation of Isis . The obligation of
Isis to consummate the transactions to be performed by it in
connection with the Closing is subject to satisfaction of the
following conditions:
(a)
The representations and warranties of AMI set forth in this
Agreement shall be true and correct in all material respects at and
as of the date hereof and as of the Closing Date.
(b)
AMI shall have performed and complied in all material respects with
all of its covenants hereunder through the Closing;
(c)
No Claim shall be pending before any court, arbitrator, other body
or administrative agency of any Governmental Authority wherein an
unfavorable injunction, judgment, order, decree, ruling or charge
would prevent consummation of any of the transactions contemplated
by this Agreement (and no such injunction, judgment, order, decree,
ruling or charge shall be in effect).
(d)
All filings with and authorizations and approvals of Governmental
Authorities that are required for the consummation of the
transactions contemplated hereby shall have been duly made and
obtained on terms reasonably satisfactory to Isis. Without
limiting the generality of the foregoing, all applicable waiting
periods (and any extensions thereof) under the HSR Act shall have
expired or otherwise been terminated.
(e)
AMI shall have delivered to Isis a certificate of AMI to the effect
that each of the conditions specified above in
Section 4.2(a) and Section 4.2(b)
is satisfied in all respects.
(f)
AMI shall have executed and delivered to Isis the Escrow Agreement
and the Escrow Agreement shall be in full force and effect.
(g)
AMI (and any other Abbott Holders (as defined in the Investor
Rights Agreement)) shall have executed and delivered to Isis a
written consent in form reasonably satisfactory to AMI and Isis,
consenting to the transactions contemplated by
Section 7.10 .
Isis may waive any
condition specified in this Section 4.2 if it executes
a writing so stating at or prior to the Closing. In the event
of any such waiver, Isis shall be deemed to have waived any claim
against AMI for failure to satisfy such condition; provided
that, except to the extent specifically and expressly set forth in
such waiver, any such waiver shall not limit Isis’ right to
recovery hereunder for a breach by AMI of any other provision of
this Agreement.
Section 5
REPRESENTATIONS AND WARRANTIES.
5.1
Representations and Warranties of Isis . As a material
inducement to AMI to enter into this Agreement, except as set forth
in the corresponding Section of the Disclosure
19
Schedules delivered to
AMI herewith on the date hereof (the “ Disclosure
Schedules ”), Isis hereby represents and warrants the
following representations and warranties are as of the date hereof,
and will be as of the Closing Date, true and correct:
(a) Power and Authority
. Each of Ibis and Isis (i) has the power, authority and
the legal right to enter into each of the Transaction Documents and
to perform its obligations hereunder and thereunder, and
(ii) has taken all necessary action required to authorize the
execution and delivery of each of the Transaction Documents and the
performance of its obligations hereunder and thereunder.
(b) Enforceability
. Each of the Transaction Documents has been duly executed
and delivered on behalf of Ibis and Isis and constitutes a legal,
valid and binding obligation of each such Party and is enforceable
against each such Party in accordance with its terms subject to the
effects of bankruptcy, insolvency or other Laws of general
application affecting the enforcement of creditor rights.
(c) Governmental Authority;
Consents . All necessary consents, approvals and
authorizations of all Governmental Authorities and other parties
required to be obtained by Ibis and Isis in connection with the
execution and delivery of each of the Transaction Documents and the
performance of their obligations hereunder and thereunder have been
obtained.
(d) No Conflicts .
The execution and delivery of each of the Transaction Documents by
each of Ibis and Isis and the performance of each such
Party’s obligations hereunder and thereunder, with or without
the passage of time or giving of notice, (1) do not and will
not conflict with or violate any requirement of Applicable Law or
any provision of the certificate of incorporation, bylaws or any
similar instrument of such Party, as applicable (2) do not and
will not require any notice, conflict with, violate, or breach or
constitute a default or require any consent or give rise to any
termination or acceleration right or the creation of any
Encumbrance on the Shares, the Additional Shares or the Remaining
Shares or any of the properties or assets of Ibis under, any
contractual obligation by which such Party is bound or subject to
and (3) do not and will not cause the suspension, revocation,
impairment, forfeiture or nonrenewal of any License applicable to
Ibis, the Business or any of Ibis’ operations, assets or
properties.
(e) Due Organization;
Qualification . Each of Ibis and Isis is a corporation
duly organized, validly existing and in good standing under the
laws of the State of Delaware, with full corporate power and
authority to enter into each of the Transaction Documents.
Except as would not reasonably be expected to have a Material
Adverse Effect, Ibis has obtained and currently maintains all
qualifications to do business as a foreign corporation in all
jurisdictions in which the character of the Business requires it to
be so qualified. Ibis has all requisite power and authority
and all authorizations and Licenses necessary to own, operate or
conduct the Business.
(f) Subsidiaries
. Ibis does not own or control any Capital Stock or other
interest of any Person. Ibis is not a participant in any
joint venture, partnership, limited liability company or similar
arrangement. Since its inception Ibis has not merged with,
acquired all or substantially all of the assets of (except pursuant
to the Contribution Agreement) or acquired the Capital Stock of or
any interest in any Person. Ibis does not hold the right to
acquire any Capital
20
Stock or interest in
any other Person or have any obligation to make any investment in
any Person and no such rights, Capital Stock or interests are
necessary for the operation of the Business. Isis does not
control or possess the power, directly or indirectly to control the
management, actions or policies of Regulus Therapeutics,
LLC.
(g) Capitalization; Voting
Rights.
(i)
The authorized Capital Stock of Ibis consists of 1,228,501
shares of Common Stock, par value $0.001 per share, [
1,114,251 ] shares of which are issued and outstanding,
1,000,000 of which are held by Isis (the “ Remaining
Shares ”) [ and 114,251 shares of which are held
by AMI ] .
(ii)
The issued and outstanding Capital Stock of Ibis as of the Closing
will consist exclusively of the Shares [ , the Additional
Shares ] and the Remaining Shares. Except as set forth
in the Investor Rights Agreement, Ibis does not have any
obligations to issue or redeem any shares of Capital Stock [
, other than with respect to the Additional Shares ] and
Ibis has not issued any Capital Stock other than the Shares,
[ the Additional Shares ] and the Remaining
Shares. No Capital Stock issued by Ibis is listed on any
stock exchange or unregulated market. Other than the
Transaction Documents, there are no agreements with Isis or Ibis or
any other Person with respect to the voting or Transfer of the
Remaining Shares.
(iii)
The Remaining Shares are: (A) duly authorized, validly issued,
fully paid and nonassessable; (B) issued in compliance with
all applicable state and federal Laws concerning the issuance of
Capital Stock; and (C) free and clear of all Encumbrances
other than the Call Option; provided, that the Remaining
Shares may be subject to restrictions on Transfer under state
and/or federal securities Laws as set forth herein or as otherwise
required by such Laws at the time a Transfer is proposed.
(iv)
The sale of the Remaining Shares to AMI hereunder is not subject to
any preemptive rights, rights of first refusal or similar
rights.
(h) Agreements;
Liabilities .
(i)
There are no judgments, orders, writs or decrees to which Ibis or
Isis is a party currently pending or, to Isis’ or Ibis’
Knowledge, threatened which would prevent Ibis or Isis from
entering into the Transaction Documents or issuing or Transferring
the Remaining Shares pursuant to the terms of the Transaction
Documents.
(ii)
Ibis has not (A) accrued, declared or paid any dividends, or
authorized or made any distribution upon or with respect to any
class or series of its Capital Stock, (B) incurred or
guaranteed any Indebtedness (other than Permitted Indebtedness),
(C) made any loans or advances to any Person, other than
advances for reasonable travel expenses to Ibis employees in the
ordinary course of business, or (D) sold, exchanged, licensed
or otherwise disposed of any of its tangible assets, other than the
sale of its inventory in the ordinary course of business.
21
(iii)
Ibis has no material obligations or liabilities (whether accrued,
absolute, or to Isis’ or Ibis’ Knowledge contingent,
unliquidated or otherwise, whether due or to become due and
regardless of when or by whom asserted), including, without
limitation, Taxes, except (A) obligations under the Ibis
Contracts made available to AMI or under Contracts entered into in
the ordinary course of business which, because of the dollar
thresholds set forth in Sections 5.1(l) and
5.1(x) , are not required pursuant to
Sections 5.1(l) and 5.1(x) below to
be described on Schedules 5.1(l) or 5.1(x)
(but not liabilities for breaches of any such Contracts),
(B) liabilities reflected on the Most Recent Balance Sheet,
(C) liabilities and obligations which have arisen after the
date of the Most Recent Balance Sheet in the ordinary course of
business (none of which is material or is a liability for breach of
contract, tort, infringement (directly, contributorily, by
inducement or otherwise), Claim or warranty (other than warranty
claims arising in the ordinary course of business in connection
with the sale of Products or under Ibis Contracts made available to
AMI, none of which warranty claims individually or in the aggregate
would reasonably be expected to have a Material Adverse Effect) and
(D) other liabilities and obligations to the extent expressly
disclosed in Schedule5.1(h)(iii) .
(i) Obligations to
Related Parties . There are no obligations of Ibis to
Affiliates, officers, directors or employees of Ibis or Isis other
than (A) for payment of salary to employees of Ibis for
services rendered in the ordinary course of business,
(B) reimbursement to employees of Ibis for reasonable expenses
incurred in the ordinary course of business on behalf of Ibis,
(C) standard employee benefits made generally available to all
employees, pursuant to the Plans described on Schedule
5.1(p)(ii) , (D) the Permitted Employee Compensation Plan or
(E) Ibis’ rights and obligations to Isis under the
Contribution Agreement and Corporate Services Agreement. To
Isis’ and Ibis’ Knowledge, all of the Contracts to
which Ibis is a party or by which the Business or any of its assets
is bound have been negotiated on an arms length basis.
(j) Title to Properties
and Tangible Assets; Liens, Etc. Ibis has good and
marketable title to its properties and tangible assets and good and
valid title to its leasehold estates, in each case subject to no
Encumbrance other than (i) Permitted Encumbrances and
(ii) rights of the U.S. federal government in certain
equipment purchased using government funds, as set forth on
Schedule 5.1(j) . The tangible assets of Ibis have
been maintained in accordance with normal industry practice and are
in good operating condition and repair (except for ordinary wear
and tear).
(k) Sufficiency of Assets
.
(i)
Except for the services, funding and facilities provided under the
Corporate Services Agreement, Ibis has all assets, properties and
rights used in or necessary to operate or conduct the Business in
all respects.
(ii)
Except the services, funding and facilities provided under the
Corporate Services Agreement and indirectly, via the Remaining
Shares, Isis and its Affiliates do not have any right, title or
interest in or to any asset, property, title or interest that is
used in or necessary to operate or conduct the Business as
conducted on and prior to the Closing Date or as contemplated to be
conducted by Ibis and Isis after the Closing Date as reflected in
the Offering Memorandum and Management Presentations.
22
Pursuant to the Contribution Agreement, Isis
has transferred to Ibis all assets, properties and rights Isis
owned or which are or were used in or necessary to operate or
conduct the Business except the services, funding and facilities
provided under the Corporate Services Agreement. No person
employed by the Division prior to the date of the Contribution
Agreement is currently employed by Isis and no former employee of
Ibis or the Division is or has been employed by Isis.
(l) Intellectual
Property .
(i)
Schedule 5.1(l)(i) sets forth a complete and correct
list of all of the following Intellectual Property used in or
necessary to operate or conduct the Business (whether owned by Ibis
or any other Person), and indicates with respect to each item,
whether Ibis owns or licenses such Intellectual Property and the
owner of any Intellectual Property covered by such license:
(A) patented or registered Intellectual Property and pending
patent applications or other applications for registrations of
Intellectual Property (including jurisdiction, registration and
application number, as applicable, and record owner),
(B) registered and material unregistered trademarks, service
marks, trade names, and Internet domain names, (C) Software
(other than unmodified, commercially available, off-the-shelf
Software purchased or licensed for less than an individual cost of
$[***] and a total cost of $[***] in the aggregate for all such
licenses), (D) material algorithms embodied in the Products
and any other material trade secrets; and (E) all other
material Intellectual Property used in or necessary to operate or
conduct the Business (including, without limitation, all
Intellectual Property set forth or required to be set forth in the
following Schedules to the Contribution Agreement:
Schedule 2.1 (Ibis Business Assets), Schedule 2.2 (Ibis
Business Patents), Schedule 2.5 (Ibis Trademarks) and Schedule 2.6
(Ibis Business Software)) (all Intellectual Property described in
the foregoing, (A) through (E), collectively, (without regard
to whether such Intellectual Property is set forth on Schedule
5.1(l)(i) ) “ Business IP ”).
(ii)
Schedule 5.1(l)(ii) sets forth a complete and correct
list of all of the following Contracts (other than licenses for
unmodified, commercially available, off-the-shelf Software
purchased or licensed for less than an individual cost of $[***]
and a total cost of $[***] in the aggregate for all such licenses)
relating to the Business IP (collectively, the “
IP Contracts ”): (A) Contracts in which Ibis
or Isis or any of their respective Affiliates is a licensee or
sublicensee of Business IP; (B) Contracts in which Ibis or
Isis or any of their respective Affiliates is a licensor or
sublicensor of Business IP; (C) Contracts to which Ibis or
Isis or any of their respective Affiliates is a party, or by which
any of the Business IP is bound, that give any third party any
right, title or interest in or to any such Business IP;
(D) Contracts with any Governmental Authority wherein any
portion of the Business IP was developed or used (“
Government Contracts ”); and (E) Contracts that
restrict Ibis’ rights in or use or disclosure of Business
IP.
(iii)
Ibis owns and possesses all right, title and interest in and to,
free and clear of all Encumbrances (other than the rights of
Governmental Authorities under Government Contracts identified in
Schedule 5.1(l)(iii) to the Intellectual Property identified
in such Schedule) or has a valid and enforceable license to use
(pursuant to a
23
written license agreement set forth and
described in Schedule 5.1(l)(ii) or a written license
for unmodified, commercially available, off-the-shelf Software
purchased or licensed for less than an individual cost of $[***]
and a total cost of $[***] in the aggregate) the Business
IP.
(iv)
Neither Isis nor any of its Affiliates (other than Ibis) has any
right, title or interest in or to any of the Business IP.
(v)
To Isis’ or Ibis’ Knowledge, neither Ibis, nor with
respect to the Business, Isis, has infringed (directly,
contributorily, by inducement or otherwise), misappropriated or
otherwise conflicted with, and the operation of the Business
(including the development, manufacture and commercialization of
the T5000 Biosensor System (including the [***] and [***]) and the
assay kits specifically listed in the [***] [***]) does not and
will not infringe (directly, contributorily, by inducement or
otherwise), misappropriate or otherwise conflict with, the patents,
trademarks, copyrights or trade secrets of any Person, and neither
Ibis nor Isis is aware of any facts that indicate a likelihood of
any of the foregoing (including without limitation, oral or written
demands or offers to license any Intellectual Property from any
Person). With respect to whether the operation or conduct of the
Business has or will infringe (directly, contributorily, by
inducement or otherwise), misappropriate or otherwise conflict with
patent, trademark, copyright or trade secrets of any Person (other
than Ibis or Isis or their respective Affiliates), the Parties
hereto are relying upon the representations and warranties
contained in this Section 5.1(l)(v) and not the
representations and warranties contained in Sections
5.1(k)(i) , 5.1(l)(viii) or
5.1(l)(ix) .
(vi)
All of the Business IP is valid and to Isis’ or Ibis’
Knowledge enforceable. Isis and Ibis have taken all necessary
actions to maintain and protect all of the Business IP, including,
without limitation, entering into confidentiality agreements with
each of its employees, consultants and independent contractors, and
customers and vendors as necessary so as not to adversely affect
the validity or enforceability thereof and have complied wi
|